Variant report
Variant | nsv514904 |
---|---|
Chromosome Location | chr19:56280636-56289564 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:103)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RFPL4AP1 | TF binding region |
ENSG00000188825 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563125227 | chr19:56280642-56280643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528928553 | chr19:56280643-56280644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1820104 | chr19:56280674-56280675 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs544929869 | chr19:56280675-56280676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528187374 | chr19:56280677-56280678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557131370 | chr19:56280695-56280696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551532861 | chr19:56280696-56280697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575314388 | chr19:56280718-56280719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571537061 | chr19:56280754-56280755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542732040 | chr19:56280764-56280765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs61348958 | chr19:56280766-56280767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531095991 | chr19:56280790-56280791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4405651 | chr19:56280791-56280792 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs567552225 | chr19:56280806-56280807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536604239 | chr19:56280819-56280820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553103360 | chr19:56280820-56280821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566938339 | chr19:56280824-56280825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539162070 | chr19:56280843-56280844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557967332 | chr19:56280847-56280848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577949293 | chr19:56280866-56280867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201374745 | chr19:56280868-56280869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543345940 | chr19:56280892-56280893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs61620824 | chr19:56280912-56280913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397958216 | chr19:56280922-56280923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs397833380 | chr19:56280953-56280954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557174200 | chr19:56280956-56280957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573860299 | chr19:56280969-56280970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542574198 | chr19:56280973-56280974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs1895379 | chr19:56280980-56280981 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs2431834 | chr19:56281001-56281002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544739019 | chr19:56281025-56281026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7258649 | chr19:56281045-56281046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531185289 | chr19:56281063-56281064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550899958 | chr19:56281075-56281076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561588786 | chr19:56281100-56281101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7258447 | chr19:56281110-56281111 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs546991973 | chr19:56281111-56281112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566904052 | chr19:56281169-56281170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs539123149 | chr19:56281207-56281208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113226022 | chr19:56281241-56281242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2547279 | chr19:56281260-56281261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139260731 | chr19:56281268-56281269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569376854 | chr19:56281275-56281276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537209995 | chr19:56281282-56281283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556892201 | chr19:56281283-56281284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140614030 | chr19:56281288-56281289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374578628 | chr19:56281291-56281292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187742665 | chr19:56281301-56281302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114882950 | chr19:56281324-56281325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552537484 | chr19:56281346-56281347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20459607 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56280000-56281800 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr19:56281200-56281800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |